Pathogenesis and treatment of recurrent vulvovaginal candidiasis

Clinical Infectious Diseases

Volumn 14, Issue , 1992, Pages SI48-S153

  Sobel, J D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; FLUCONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL FLORA; CANDIDIASIS; CELLULAR IMMUNITY; CONFERENCE PAPER; FEMALE; GASTROINTESTINAL TRACT; HOST RESISTANCE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MORPHOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT INFECTION; REINFECTION; RELAPSE; SEXUAL TRANSMISSION; STRAIN DIFFERENCE; TOPICAL DRUG ADMINISTRATION; VULVOVAGINITIS;

ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; CHRONIC DISEASE; FEMALE; HUMAN; RECURRENCE;

EID: 0026593521     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/14-Supplement_1-S148     Document Type: Article

References (47)

1. Sobel JD. Recurrent vulvovaginal candidosis. What we know and what we don't. Ann Intern Med 1984;101:390-2.
2. Sobel JD. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986;315:1455-8.
3. Odds FC. Genital candidosis. Clin Exp Dermatol 1982;7:345-54.
4. Miles MR, Olsen L, Rogers A. Recurrent vaginal candidiasis. Importance of an intestinal reservoir. JAMA 1977;238:1836-7.
5. Bertholf ME, Stafford MJ. Colonization of Candida albicans in vagina, rectum, and mouth. J Family Pract 1983;16:919-24.
6. O'Connor MI, Sobel JD. Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans. J Infect Dis 1986;154:358-63.
7. Milne JD, Warnock DW. Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis. Br J Vener Dis 1979;55:362-6.
8. Vellupillai S, Thin RN. Treatment of vulvovaginal yeast infection with nystatin. Practitioner 1977;219:897-901.
9. Meinhof WL. Demonstration of typical features of individual Candida albicans strains as a means of studying sources of infection. Chemotherapy 1982;28(suppl 1):51-5.
10. Rodin P, Kolator B. Carriage of yeasts on the penis. BMJ 1976; 1: 1123-4.
11. Thin RN, Leighton M, Dixon MJ. How often is genital yeast infection sexually transmitted? BMJ 1977;2:93-4.
12. Davidson F. Yeasts and circumcision in the male. Br J Vener Dis 1977;53:121-2.
13. Ogunbanjo B. Isolation of yeasts from male contacts of women with vaginal candidosis. Genitourinary Med 1988;64:135-6.
14. Horowitz BJ, Edelstein SW, Lippman L. Sexual transmission of Candida. Obstet Gynecol 1987;69:883-6.
15. Odds FC. Candidosis of the genitalia. In: Odds FC, ed. Candida and candidosis. 2nd ed. London: Bailliere Tindall, 1988:124-35.
16. Garcia-Tamayo J, Castillo G, Martinez AJ. Human genital candidosis. Histochemistry, scanning and transmission electron microscopy. Acta Cytol (Baltimore) 1982;26:7-14.
17. Soil DR. High-frequency switching in Candida albicans and its relations to vaginal candidiasis. Am J Obstet Gynecol 1988;158:997-1001.
18. Slutsky B, Buffo J, Soil DR. High-frequency switching colony morphology in Candida albicans. Science 1985;230:666-9.
19. Soil DR, Langtimm CJ, McDowell J, Hicks J, Galask R. High-frequency switching in Candida strains isolated from vaginitis patients. J Clin Micro 1987;25:161 1-22.
20. Horowitz BJ. Topical flucytosine therapy for chronic recurrent Candida tropicalis infections. J Reprod Med 1986;31:821-4.
21. Seligman SA. Treatment of vulval candidosis with 5-fluorocytosine. BMJ 1974;3:173-4.
22. Speller DCE, Warnock DW. Vaginal candidosis. BMJ 1976;2:107.
23. Cauwenbergh G. Vaginal candidiasis: evolving trends in the incidence and treatment of non-Candida albicans infections. Curr Probl Obstet Gynecol Fertil 1990;Nov/Dec:241-5.
24. Waldman RH, Crutz JM, Rowe DS. Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clin Exp Immunol 1972;10:427-34.
25. Gough PM, Warnock DW, Richardson MD, Mansell NJ, King JM. IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis. Sabouraudia 1984;22:265-71.
26. Caruso LJ. Vaginal moniliasis after tetracycline therapy. Am J Obstet Gynecol 1964;90:374-8.
27. Oriel JD, Waterworth PM. Effect of minocycline and tetracycline on the vaginal yeast flora. J Clin Pathol 1975;28:403-6.
28. Liljemark WF, Gibbons RJ. Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect Immun 1973;8:846-9.
29. Auger P, Joly J. Microbial flora associated with Candida albicans vulvovaginitis. Obstet Gynecol 1980;55:397-401.
30. Narayanan TK, Rao GR. Beta-indole-ethanol and beta-indolelactic acid production by Candida species: their antibacterial and autoantibiotic action. Antimicrob Agents Chemother 1976;9:375-80.
31. Rhoads JL, Wright C, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3105-7.
32. Witkin SS, Yu IR, Ledger WJ. Inhibition of Candida albicans-induced lymphocyte proliferation by lymphocytes and sera from woman with recurrent vaginitis. Am J Obstet Gynecol 1983;147:809-11.
33. Hobbs JR, Briden D, Davidson F, Kahan M, Oates JK. Immunological aspects of candidal vaginitis. Proc R Soc Med 1977;70(suppl 4): 11-4.
34. Witkin SS, Hirsch J, Ledger WJ. A macrophage defect in women with recurrent candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol 1986;155:790-5.
35. Witkin SS, Jeremias J, Ledger WJ. A localized vaginal allergic response in women with recurrent vaginitis. J Allergy Clin Immunol 1988;81:412-6.
36. 2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun 1990;58:260-2.
37. Sobel JD. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol 1985;65: 435-40.
38. Davidson F, Mould RF. Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br J Vener Dis 1978;54:176-83.
39. Balsdon MJ, Tobin JM. Recurrent vaginal candidosis: prospective study of effectiveness of maintenance miconazole treatment. Geni-tourin Med 1988;64:124-7.
40. Kinsman OS, Collard AF. Hormonal factors in vaginal candidosis in rats. Infect Immun 1986;53:498-504.
41. Dennerstein GJ. Depot-Provera in the treatment of recurrent vulvovaginal candidosis. J Reprod Med 1986;31:801-3.
42. Sobel JD, Schmitt C, Meriwether C. Clotrimazole treatment of recurrent and chronic Candida vulvovaginitis. Obstet Gynecol 1989; 73:330-4.
43. Brammer KW. Treatment of vaginal candidosis with a single oral dose of fluconazole. Eur J Clin Microbiol Infect Dis 1988;7:364-7.
44. International Multicenter Trial. A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Br J Obstet Gynecol 1989;96:226-32.
45. Sobel JD. Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. Int J Gynaecol Obstet 1992 (in press).
46. Nystatin Multicenter Study Group. Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Am J Obstet Gynecol 1986;155:651-4.
47. Rosedale N, Browne K. Hyposensitization in the management of recurring vaginal candidiasis. Ann Allergy 1979;43(4):250-3.